Cargando…
Improving the N-terminal diversity of sansanmycin through mutasynthesis
BACKGROUND: Sansanmycins are uridyl peptide antibiotics (UPAs), which are inhibitors of translocase I (MraY) and block the bacterial cell wall biosynthesis. They have good antibacterial activity against Pseudomonas aeruginosa and Mycobacterium tuberculosis strains. The biosynthetic gene cluster of s...
Autores principales: | Shi, Yuanyuan, Jiang, Zhibo, Lei, Xuan, Zhang, Ningning, Cai, Qiang, Li, Qinglian, Wang, Lifei, Si, Shuyi, Xie, Yunying, Hong, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858918/ https://www.ncbi.nlm.nih.gov/pubmed/27154005 http://dx.doi.org/10.1186/s12934-016-0471-1 |
Ejemplares similares
-
Expanding structural diversity of 5′-aminouridine moiety of sansanmycin via mutational biosynthesis
por: Lu, Yuan, et al.
Publicado: (2023) -
Diversely Functionalised Cytochalasins through Mutasynthesis and Semi‐Synthesis
por: Wang, Chongqing, et al.
Publicado: (2020) -
Preparation of new alkyne-modified ansamitocins by mutasynthesis
por: Harmrolfs, Kirsten, et al.
Publicado: (2014) -
Novel nikkomycin analogues generated by mutasynthesis in Streptomyces ansochromogenes
por: Feng, Chi, et al.
Publicado: (2014) -
In Vitro Mutasynthesis of Lantibiotic Analogues Containing Nonproteinogenic Amino Acids
por: Levengood, Matthew R., et al.
Publicado: (2009)